Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX

The Vanguard Group's stake in Amylyx Pharmaceuticals, Inc. fell to 4.94% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Oct 30, 2025

The Vanguard Group's stake in Amylyx Pharmaceuticals, Inc. fell to 4.94%, 5,273,750 shares, as a passive investor on Sep 30, 2025. Filed Oct 30, 2025 (Schedule 13G/A).

Stake
4.94%
Shares
5,273,750
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
The Vanguard Group4.94%5,273,750

Source

View original at SEC

Related